Acute Drug-Allergic Tubulointerstitial Nephritis

1. Raghavan R, Shawar S. Mechanisms of Drug-Induced Interstitial Nephritis. Adv Chronic Kidney Dis. 2017; 24(2): 64-71.10.1053/j.ackd.2016.11.00428284381Search in Google Scholar

2. Perazella MA. Renal Vulnerability to Drug Toxicity. CJASN. 2009; 4(7): 1275-1283.10.2215/CJN.0205030919520747Search in Google Scholar

3. Perazella MA. Drug-induced nephropathy: an update. Expert Opin Drug Saf. 2005; 4(4): 689-706.10.1517/14740338.4.4.68916011448Search in Google Scholar

4. Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta. 2005; 351(1-2): 31-47.10.1016/j.cccn.2004.09.00515563870Search in Google Scholar

5. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 2001; 60(2): 804-817.10.1046/j.1523-1755.2001.060002804.x11473672Search in Google Scholar

6. Perazella MA, Markowitz GS: Drug-induced acute interstitial nephritis. Nat Rev Nephrol. 2010; 6(8): 461-470.10.1038/nrneph.2010.7120517290Search in Google Scholar

7. Wilson DM, Turner DR, Cameron JS, Ogg CS, Brown CB, Chantler C. Value of renal biopsy in acute intrinsic renal failure. Br Med J. 1976; 2(6033): 459-461.10.1136/bmj.2.6033.4591687565953608Search in Google Scholar

8. Perazella MA. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol. 2014; 81(6): 381-388.10.5414/CN108301432685624691017Search in Google Scholar

9. Nussbaum EZ, Perazella MA. Diagnosing acute interstitial nephritis: considerations for clinicians. Clin Kidney J. 2019; 12(6): 808-813.Search in Google Scholar

10. Nast CC. Medication-Induced Interstitial Nephritis in the 21st Century. Adv Chronic Kidney Dis. 2017; 24(2): 72-79.10.1053/j.ackd.2016.11.01628284382Search in Google Scholar

11. Stillman IE Lima EQ Burdmann EA. Renal biopsies in acute kidney injury: who are we missing? Clin J Am Soc Nephrol. 2008; 3(3): 647-648.10.2215/CJN.0111030818385394Search in Google Scholar

12. Raghavan R, Eknoyan G. Acute interstitial nephritis -a reappraisal and update. Clin Nephrol. 2014; 82(3): 149-162.10.5414/CN10838Search in Google Scholar

13. Farrington K, Levison DA, Greenwood RN, Cattell WR, Baker LR. Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med. 1989; 70(263): 221-233.Search in Google Scholar

14. Rossert JA, Fischer EA. Acute Interstitial Nephritis. În: Feehally J, Floege J, Tonelli M, Johnson RJ (editori): Comprehensive Clinical Nephrology, ediţia a 6-a, Elsevier. 2019; pag. 729-737.10.1016/B978-0-323-05876-6.00060-5Search in Google Scholar

15. Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, Nasr SH. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series. Am J Kidney Dis. 2014; 64(4): 558-566.10.1053/j.ajkd.2014.04.02724927897Search in Google Scholar

16. Moledina DG, Perazella MA. Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol. 2017; 12(12): 2046-2049.10.2215/CJN.07630717571827928893923Search in Google Scholar

17. Praga M, Sevillano A, Auñón P, González E. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant. 2015; 30(9): 1472-1479.10.1093/ndt/gfu32625324356Search in Google Scholar

18. Blank ML, Parkin L, Paul C, Herbison P. A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int. 2014; 86(4): 837-844.10.1038/ki.2014.74418418724646856Search in Google Scholar

19. Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Nephrol. 2007; 68(2): 65-72.Search in Google Scholar

20. Pusey CD, Saltissi D, Bloodworth L, Rainford DJ, Christie JL. Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q J Med. 1983; 52(206): 194-211.Search in Google Scholar

21. Nussbaum EZ, Perazella MA. Update on the nephrotoxicity of novel anticancer agents. Clin Nephrol 2018; 89(3): 149-165.10.5414/CN10937129350175Search in Google Scholar

22. Perazella MA, Shirali AC. Nephrotoxicity of cancer immunotherapies: past, present and future. J Am Soc Nephrol; 29(8): 2039-2052.10.1681/ASN.2018050488606507929959196Search in Google Scholar

23. Airy M, Raghavan R, Truong LD, Eknoyan G. Tubulointerstitial nephritis and cancer chemotherapy: update on a neglected clinical entity. Nephrol Dial Transplant. 2013; 28(10): 2502-2509.10.1093/ndt/gft24124009289Search in Google Scholar

24. Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, Nasr SH. Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly. Kidney Int. 2015; 87(2): 458-464.10.1038/ki.2014.29425185078Search in Google Scholar

25. Neilson EG. Pathogenesis and therapy of interstitial nephritis. Kidney Int. 1989; 35(5): 1257-1270.10.1038/ki.1989.118Search in Google Scholar

26. Krishnan N, Perazella MA. Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment. Iran J Kidney Dis. 2015; 9(1): 3-13.Search in Google Scholar

27. Galpin JE, Shinaberger JH, Stanley TM, Blumenkrantz MJ, Bayer AS, Friedman GS, Montgomerie JZ, Guze LB, Coburn JW, Glassock RJ. Acute interstitial nephritis due to methicillin. Am J Med. 1978; 65(5): 756-765.10.1016/0002-9343(78)90793-3Search in Google Scholar

28. Baldwin DS, Levine BB, McCluskey RT, Gallo GR. Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med. 1968; 279(23): 1245-1252.10.1056/NEJM196812052792302Search in Google Scholar

29. Schubert C, Bates WD, Moosa MR. Acute tubulointerstitial nephritis related to antituberculous drug therapy. Clin Nephrol. 2010; 73(6): 413-.10.5414/CNP73413Search in Google Scholar

30. Praga M, Appel GB. Clinical manifestations and diagnosis of acute interstitial nephritis. UPTODATE 2018. Disponibil la: https://www.uptodate.com, accesat aprilie 2020.Search in Google Scholar

31. Ten RM, Torres VE, Milliner DS, Schwab TR, Holley KE, Gleich GJ. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc. 1988; 63(9): 921-930.10.1016/S0025-6196(12)62697-4Search in Google Scholar

32. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984; 310(9): 563-572.10.1056/NEJM1984030131009056363936Search in Google Scholar

33. Belliere J, Meyer N, Mazieres J, Ollier S, Boulinguez S, Delas A, Ribes D, Faguer S. Acute interstitial nephritis related to immune checkpoint inhibitors. Br J Cancer. 2016; 115(12): 1457-146.10.1038/bjc.2016.358515535827832664Search in Google Scholar

34. Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2004; 19(1): 8-11.10.1093/ndt/gfg46414671029Search in Google Scholar

35. Kodner CM, Kudrimoti A. Diagnosis and management of acute interstitial nephritis. Am Fam Physician. 2003; 67(12): 2527-2534.Search in Google Scholar

36. Praga M, González E. Acute interstitial nephritis. Kidney Int. 2010; 77(11): 956-961.10.1038/ki.2010.8920336051Search in Google Scholar

37. Saha H, Mustonen J, Helin H, Pasternack A. Limited value of the fractional excretion of sodium test in the diagnosis of acute renal failure. Nephrol Dial Transplant. 1987; 2(2): 79-82.Search in Google Scholar

38. Muriithi AK, Nasr SH, Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol. 2013; 8(11):1857-1862.10.2215/CJN.01330213381789824052222Search in Google Scholar

39. Espejo B, Herrero JC, Torres A, Martínez A, Gutiérrez E, Morales E, González E, Bueno B, Valentín MO, Praga M. Immunoallergic interstitial nephritis vs. cholesterol atheroembolism. Differentiating characteristics. Nefrologia. 2003; 23(2): 125-130.Search in Google Scholar

40. Hiraoka M Hori C Tsuchida S Tsukahara H Sudo M Ultrasonographic findings of acute tubulointerstitial nephritis. Am J Nephrol. 1996; 16(2): 154-158.10.1159/000168989Search in Google Scholar

41. Linton AL, Richmond JM, Clark WF, et al. Gallium67 scintigraphy in the diagnosis of acute renal disease. Clin Nephrol. 1985; 24(2): 84-87.Search in Google Scholar

42. Koselj M Kveder R Bren AF Rott T Acute renal failure in patients with drug-induced acute interstitial nephritis. Ren Fail. 1993; 15(1): 69-72.10.3109/08860229309065575Search in Google Scholar

43. Graham F, Lord M, Froment D, Cardinal H, Bollée G. The use of gallium-67 scintigraphy in the diagnosis of acute interstitial nephritis. Clin Kidney J. 2016; 9(1): 76-81.10.1093/ckj/sfv129Search in Google Scholar

44. Eknoyan G Raghavan R Acute tubulointerstitial nephritis. În: Coffman T, Falk R, Molitoris B, Neilson E, Schrier RW (editori). Schrier’s Diseases of the Kidney. Ediţia a 9-a. Philadelphia, PA: Lippincott, Williams&Wilkins. 2013; pag.994-1017.Search in Google Scholar

45. Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol. 2000; 54(3): 179-190.Search in Google Scholar

46. Fernandez-Juarez G, Perez JV, Caravaca-Fontán F, Quintana L, Shabaka A, Rodriguez E, Gadola L, de Lorenzo A, Cobo MA, Oliet A, Sierra M, Cobelo C, Iglesias E, Blasco M, Galeano C, Cordon A, Oliva J, Praga M, Spanish Group for the Study of Glomerular Diseases (GLOSEN). Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis. Clin J Am Soc Nephrol. 2018; 13(12): 1851-1858.10.2215/CJN.01390118Search in Google Scholar

47. Preddie DC, Markowitz GS, Radhakrishnan J, Nickolas TL, D’Agati VD, Schwimmer JA, Gardenswartz M, Rosen R, Appel GB. Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol. 2006; 1(4): 718-722.10.2215/CJN.01711105Search in Google Scholar

48. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008; 336(7634): 2-3.10.1136/bmj.39406.449456.BESearch in Google Scholar

49. Ruffenach SJ, Siskind MS, Lien YH. Acute interstitial nephritis due to omeprazole. Am J Med. 1992; 93(4): 472-473.10.1016/0002-9343(92)90181-ASearch in Google Scholar

50. Torpey N, Barker T, Ross C. Drug-induced tubulointerstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrol Dial Transplant. 2004; 19(6): 1441-1446.10.1093/ndt/gfh13715004262Search in Google Scholar

51. Geevasinga N, Kairaitis L, Rangan GK, Coleman PL. Acute interstitial nephritis secondary to esomeprazole. Med J Aust. 2005; 182(5): 235-236.10.5694/j.1326-5377.2005.tb06675.x15748135Search in Google Scholar

52. Geevasinga N, Coleman PL, Roger SD. Rabeprazole-induced acute interstitial nephritis. Nephrology (Carlton). 2005; 10(1): 7-9.10.1111/j.1440-1797.2005.00365.x15705174Search in Google Scholar

53. Klassen S, Krepinsky JC, Prebtani AP. Pantoprazole-induced acute interstitial nephritis. CMAJ. 2013; 185(1): 56-59.10.1503/cmaj.120954353778023109611Search in Google Scholar

54. Moledina DG, Perazella MA. PPIs and kidney disease: from AIN to CKD. J Nephrol. 2016; 29(5): 611-616.10.1007/s40620-016-0309-227072818Search in Google Scholar

55. Sampathkumar K, Ramalingam R, Prabakar A, Abraham A. Acute interstitial nephritis due to proton pump inhibitors. Indian J Nephrol. 2013; 23(4): 304-307.10.4103/0971-4065.114487374197923960351Search in Google Scholar

56. Antoniou T, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Garg AX, Paterson M, Juurlink DN. Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. CMAJO. 2015; 3(2): E166-E171.10.9778/cmajo.20140074457183026389094Search in Google Scholar

57. Simpson IJ, Marshall MR, Pilmore H, Manley P, Williams L, Thein H, Voss D. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology (Carlton). 2006; 11(5): 381-385.10.1111/j.1440-1797.2006.00651.x17014549Search in Google Scholar

58. Geevasinga N, Coleman PL, Webster AC, Roger SD. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol. 2006; 4(5): 597-604.10.1016/j.cgh.2005.11.00416630752Search in Google Scholar

59. Morschel CF, Mafra D, Eduardo JCC. The relationship between proton pump inhibitors and renal disease. J Bras Nefrol. 2018; 40(3): 301-306.10.1590/2175-8239-jbn-2018-0021653396030010692Search in Google Scholar

60. Ball S, Cook T, Hulme B, Palmer A, Taube D. The diagnosis and racial origin of 394 patients undergoing renal biopsy: An association between Indian race and interstitial nephritis. Nephrol Dial Transplant. 1997; 12(1): 71-77.10.1093/ndt/12.1.719027776Search in Google Scholar

61. Manika K, Tasiopoulou K, Vlogiaris L, Lada M, Papaemmanouil S, Zarogoulidis K, Kioumis I. Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication. Ren Fail. 2013; 35(8): 1179-1181.10.3109/0886022X.2013.81556723883374Search in Google Scholar

62. De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features. Am J Kidney Dis. 1998; 31(1): 108-115.10.1053/ajkd.1998.v31.pm94284609428460Search in Google Scholar

63. Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin: a study of 25 patients. Am J kidney Dis. 2002; 14(4): 690-696.10.1053/ajkd.2002.3567512324902Search in Google Scholar

64. Ortiz A, Barat A, Oliva H. Acute kidney failure induced by rifampicin. Nefrologia. 2001; 21(1): 92-94.Search in Google Scholar

65. Min HK, Kim EO, Lee SJ, Chang YK, Suh KS, Yang CW, Kim SY, Hwang HS. Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis. BMC Nephrol. 2013; 14:13.10.1186/1471-2369-14-13355835123320835Search in Google Scholar

66. Alper AB Jr, Meleg-Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am J Kidney Dis. 2002; 40(5): 1086-1090.10.1053/ajkd.2002.3634912407655Search in Google Scholar

67. Andrews PA, Sampson SA. Topical non-steroidal drugs are systemically absorbed and may cause renal disease. Nephrol Dial Transplant. 1999; 14(1): 187-189.10.1093/ndt/14.1.18710052505Search in Google Scholar

68. Krummel T, Dimitrov Y, Moulin B, Hannedouche T. Drug points: Acute renal failure induced by topical ketoprofen. BMJ. 2000; 320(7227): 93.10.1136/bmj.320.7227.932725610625264Search in Google Scholar

69. Kikuchi H, Aoyagi M, Nagahama K, Yajima Y, Yamamura Co, Arai Y, Hirasawa S, Aki S, Inaba N, Tanaka H, Tamura T. Case Report: Nephrotic-range Proteinuria and Interstitial Nephritis Associated with the Use of a Topical Loxoprofen Patch. Intern Med. 2014; 53(11): 1131-1135.10.2169/internalmedicine.53.166924881736Search in Google Scholar

70. Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019; 41(1): 124-130.10.1590/2175-8239-jbn-2018-0107Search in Google Scholar

71. Jung JH, Kang KP, Kim W, Park SK, Lee S. Nonsteroidal antiinflammatory drug induced acute granulomatous interstitial nephritis. BMC Res Notes. 2015; 8:793.10.1186/s13104-015-1788-2468114226674186Search in Google Scholar

72. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984; 310(9): 563-572.10.1056/NEJM1984030131009056363936Search in Google Scholar

73. Mohammed EP, Stevens JM. Recurrence of Arthrotec-associated nephrotic syndrome with re-challenge. Clin Nephrol. 2000; 53(6): 483-485.Search in Google Scholar

74. Ejaz P, Bhojani K, Joshi VR. NSAIDs and Kidney. JAPI. 2004; 52: 632-640.Search in Google Scholar

75. Nawaz FA, Larsen CP, Troxell ML. Membranous Nephropathy and Nonsteroidal Anti-inflammatory Agents. AJKD. Kidney Biopsy Teaching Case. 2013; 62(5): 1012-1017.Search in Google Scholar

76. Feinfeld DA, Olesnicky L, Pirani CL, Appel GB. Nephrotic syndrome associated with use of the nonsteroidal anti-inflammatory drugs. Case report and review of the literature. Nephron. 1984; 37(3): 174-179.10.1159/0001832396738768Search in Google Scholar

77. Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013; 16(5): 821-847.10.18433/J3VW2FSearch in Google Scholar